Back
ECARX Holdings Vs. Denali Therapeutics Industry Stock Comparison
Sell
36
ECX
ECARX Holdings
Last Price:
1.77
Seasonality Move:
-34.51%
Buy
56
DNLI
Denali Therapeutics
Last Price:
31.56
Seasonality Move:
17.79%
Sell
36
ECARX Holdings (ECX)
is a Sell
Is ECARX Holdings a Buy, Sell or Hold?
- The current ECARX Holdings [ECX] share price is $1.77. The Score for ECX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- ECX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $30.76. The Score for DNLI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ECX Stock Price Chart
What is ECARX Holdings's stock price today?
-
The ECARX Holdings share price today is $1.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ECX is experiencing slight selling pressure.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $30.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing selling pressure, which indicates risk of future bearish movement.
ECX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 53.25 | Buy |
Chaikin Money Flow: | -17433 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.67 - 1.79) | Buy |
Bollinger Bands (100): | (1.33 - 1.85) | Buy |
DNLI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.79 | Buy |
Relative Strength Index (14 RSI): | 78.12 | Buy |
Chaikin Money Flow: | -939708 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.39 - 28.19) | Buy |
Bollinger Bands (100): | (19.07 - 25.27) | Buy |
ECX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.75 | Buy |
20-day SMA: | 1.74 | Buy |
50-day SMA: | 1.7 | Buy |
200-day SMA: | 1.95 | Sell |
8-day EMA: | 1.75 | Buy |
20-day EMA: | 1.73 | Buy |
50-day EMA: | 1.7 | Buy |
200-day EMA: | 2.21 | Sell |
DNLI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.69 | Buy |
20-day SMA: | 26.4 | Buy |
50-day SMA: | 24.37 | Buy |
200-day SMA: | 20.59 | Buy |
8-day EMA: | 29.03 | Buy |
20-day EMA: | 26.97 | Buy |
50-day EMA: | 24.8 | Buy |
200-day EMA: | 22.21 | Buy |
ECARX Holdings Earnings Growth & ECX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and an increase next year of $0.23 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.
ECARX Holdings Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Denali Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |